Jason S. Fisherman

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA.

MDeverywhere, Inc. provides physician revenue cycle management and medical billing software solutions. It offers claim submission, electronic eligibility verification, payment posting, claim follow-up, denial management, insurance rule creation, insurance contract definition, patient recalls, and appointment reminder calls. The company was founded by Lloyd A. Hey and David T. Fetterolf in 1995 and is headquartered in Durham, NC.

Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom.

TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA.

White Cube Management LLC provides management services. The private company is based in Boston, MA.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts.

Prexa Pharmaceuticals, Inc. developed oral small molecule monoamine reuptake inhibitors that act potently at the dopamine transporter. It engaged in developing small molecules designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as ADHD, depression, and Parkinson's disease. The company was founded in 2006 and was headquartered in Boston, MA.

Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom.

Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.

Cellzome AG provides drug discovery services. It is a research company with proprietary proteomics technology for target and lead identification and a drug discovery program in Alzheimer's disease. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.

Oridion Systems Ltd. develops medical devices for patient safety monitoring. It produces medical devices (hardware) and patient interfaces (consumables) based on its patented Microstream and Smart Capnography technologies for the enhancement of patient safety and clinical outcomes. It provides solutions for respiratory monitoring and airway management for patients which includes non-incubated patients, premature newborns and clinical environments which includes procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport and alternate care. It operates in Jerusalem, Israel, Needham, Massachusetts and the United States of America. The company was founded by Yacov Bubis in 1987 and is headquartered in Jerusalem, Israel.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Trident Pharmaceuticals, Inc. develops novel biologics for the treatment of autoimmune disorders. The company was founded by Charles M. Cohen and Robin Brown in March 2006 and is headquartered in Boston, MA.

AlloMek Therapeutics LLC develops and discovers pharmaceutical products for cancer therapies. It offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. The company was founded by Khire R. Uday and Barry Hart in 2010 and is headquartered in Farmington, CT.